DDX39B and colorectal carcinoma: Moreover, a Kaplan–Meier analysis of the overall survival of CRC patients revealed that patients with high DDX39B expression levels had a shorter overall survival time than patients with low DDX39B expression levels (Fig. 1D, P = 0.031).